Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
Topic
- Advertising (236)
- COVID-19 (55)
- Compliance and enforcement (48)
- Vaping hub (33)
- Import and export (21)
- Medicinal cannabis hub (19)
- Safety monitoring and information (13)
- Scheduling (national classification system) (13)
- Manufacturing (11)
- Weight loss products (8)
- Legislation (7)
- Labelling and packaging (4)
- Shortages and supply disruptions (4)
- Cosmetics (3)
- Prescription opioids hub (2)
- Unique Device Identification (UDI) hub (2)
- Committees and advisory bodies (1)
- Fees and payments (1)
- Sunscreens (1)
Search
530 result(s) found, displaying 476 to 500
-
Media releasesInformation about influenza vaccines for use in 2018
-
Media releasesIn reference to the ABC’s Fact Check article “Will the move to make codeine prescription-only save a100 lives a year” the Therapeutic Goods Administration (TGA) would like to clarify:
-
Media releasesThe medicines’ regulator is not proposing and will not be stopping GPs from prescribing high dose opioids
-
Media releasesThe TGA has issued a discussion paper on the use and misuse of prescription strong opioids, such as oxycodone, and whether there is a need for specific regulatory responses
-
Media releasesInformation about the TGA operations over the 2015/16 Christmas/New Year period
-
Media releasesStage two report for the Review of Medicines and Medical Devices has been released
-
Media releasesThe Therapeutic Goods Administration has published an interim decision on a proposal to up-schedule codeine
-
Media releasesThe TGA has imposed two new conditions on the inclusion of the SynchroMed II Programmable Pump in the Australian Register of Therapeutic Goods
-
Media releasesFrom 1 July 2015 commercial IVD medical devices will be monitored under the Regulatory Compliance Framework
-
Media releasesFrom 1 July 2015, new guidance and forms for Additional trade names and Extensions of Indications applications will be available
-
Media releasesBetween 24 May and 16 June, the ACBPS, TGA and APVMA took part in an international crackdown on fake and illegal medicines
-
Media releases
-
Media releasesThe TGA is aware of regulatory action undertaken by the US Food and Drug Administration (FDA) in relation to the Maquet manufacturing facility in Hudson, New Hampshire, USA
-
Media releasesNext Tuesday we will be launching the new TGA Business Services site.
-
Media releases
-
-
Compliance undertakingsUndertaking to the Secretary of the Australian Government Department of Health given for the purposes of section 42YL of the Act
-
Media releasesThe TGA and NPS Medicinewise have worked together to create two interactive online learning modules
-
Media releasesThe Australian and New Zealand Governments have agreed to cease efforts to establish a joint therapeutic products regulator, the Australia New Zealand Therapeutic Products Agency (ANZTPA).
-
-
Media releasesThe annual report contains information about hip, knee and shoulder orthopaedic implants that are having higher-than-expected rates of revision.
-
Media releases
-
-
-
Media releasesNews about information to assist importers, manufacturers and suppliers to determine whether their products are food or therapeutic goods